1. bookVolume 15 (2022): Issue 1 (June 2022)
Journal Details
License
Format
Journal
eISSN
1313-9053
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English
Open Access

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis

Published Online: 13 Jul 2022
Volume & Issue: Volume 15 (2022) - Issue 1 (June 2022)
Page range: 70 - 73
Received: 18 Jan 2022
Accepted: 11 May 2022
Journal Details
License
Format
Journal
eISSN
1313-9053
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English

1. Ganev T, Petkova L, Statelov T, Stamboliyski V, Hinev A, Evtimov N. Clinical experience in the treatment of invasive bladder cancer. Uronet. 2011;3:29-34. Search in Google Scholar

2. Evtimov N, Ganev T, Stamboliyski V. Complications in the choice of laparoscopic surgical technique. Urology. 2015:2;36-41. Search in Google Scholar

3. Arends TJ, Nativ O, Maffezzini M. et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol. 2016 Jun;69(6):1046-52.10.1016/j.eururo.2016.01.00626803476 Search in Google Scholar

4. Chou R, Selph S, Buckley DI. et al. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. J Urol. 2017 May;197(5):1189-99.10.1016/j.juro.2016.12.09028027868 Search in Google Scholar

5. Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer - a current perspective. Nat Rev Urol. 2014 Mar;11(3):153-62.10.1038/nrurol.2014.1524492433 Search in Google Scholar

6. Porten SP, Leapman MS, Greene KL. Intravesical chemotherapy in non-muscle-invasive bladder cancer. Indian J Urol. 2015 Oct-Dec;31(4): 297-303.10.4103/0970-1591.166446462691326604440 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo